ODAC 30% Off Registration, Use Code: JDD30
Skip to main content
AestheticsFeatured Articles

What are the Skincare Benefits of Niacinamide?

By September 28, 2020No Comments

Featured Article

Featured Article

A 2016 study from Journal of Drugs in Dermatology suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read more

A 2016 study from Journal of Drugs in Dermatology (“Efficacy and Tolerability of a Skin Brightening/Anti-Aging Cosmeceutical Containing Retinol 0.5%, Niacinamide, Hexylresorcinol, and Resveratrol“), which was recently cited in an article on Prevention.com, suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection. 

Patricia Farris MD, Joshua Zeichner MD, and Diane Berson MD

 

Consumers are increasingly interested in over-the-counter skin care products that can improve the appearance of photodamaged and aging skin. This 10-week, open-label, single- center study enrolled 25 subjects with mild to moderate hyperpigmentation and other clinical stigmata of cutaneous aging including fine lines, sallowness, lack of clarity, and wrinkling. Their mean age was 53.4±7.7 years. The test product contained retinol 0.5% in combination with niacinamide 4.4%, resveratrol 1%, and hexylresorcinol 1.1% in a moisturizing base. Subjects were provided a skin care regimen including a cleanser, hydrating serum, moisturizer, and an SPF 30 sunscreen for daily use. The test product was applied only at night.

The use of this skin brightening/anti-aging cosmeceutical was found to provide statistically significant improvements in all efficacy endpoints by study end. Fine lines, radiance, and smoothness were significantly improved as early as week 2 (P<.001). By week 4, hyperpigmentation, overall skin clarity, evenness of skin tone, and wrinkles showed statistically significant improvement compared to baseline. Mild retinoid dermatitis including flaking and redness occurred early in the study as reflected by tolerability scores. By week 10, subjects reported no stinging, itching, dryness, or tingling.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read Full Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD featuring Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials

Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials

| Featured Articles, Latest News | No Comments
Targeting BTK in Cutaneous Lupus: What New Clinical Trial Data Reveals for Dermatologists Have you explored the newest systematic review from the Journal of Drugs in Dermatology examining the potential of…
Journal of Drugs in Dermatology JDD featuring Tackling Female Hair Loss: Gentle Topicals vs. In-Office Mesotherapy

Tackling Female Hair Loss: Gentle Topicals vs. In-Office Mesotherapy

| Alopecia, Dyspigmentation, Featured Articles, Hair, Latest News, Women | No Comments
Weighing efficacy and risks across non-surgical hair restoration methods Hair restoration continues to dominate clinical inquiries, representing some of JDD's most read topics that we are bringing back out of…
Journal of Drugs in Dermatology JDD featuring Impetigo Antibiotic Stewardship and the Need for Treatment Alternatives

Impetigo Antibiotic Stewardship and the Need for Treatment Alternatives

| Featured Articles, JDD Highlights, Latest News | No Comments
Rethinking Impetigo Management: Why Antimicrobial Stewardship Matters Now in Dermatology This is a must-read consensus review from the Journal of Drugs in Dermatology examining how rising antimicrobial resistance is reshaping…

Leave a Reply